tirzepatide cardiovascular outcomes trial results august 2025 with versus Dulaglutide in Type 2 Diabetes Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular

Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and breastfeeding

The LillyDirect self-pay program usually offers better pricing for uninsured or uncovered patients

A 2016 meta-analysis in JAMA found behavioral programs yielded average weight loss of 58% of baseline body weight over 12 months

Post-marketing surveillance and real-world data Beyond clinical trials, post-marketing surveillance through the FDA Adverse Event Reporting System (FAERS) has produced mixed but ultimately reassuring results

Blood pressure profiles in infants with hypoxic ischemic encephalopathy (Hie), response to dopamine, and association with brain injury